Dataset Information

Antibacterial Textile Based on Hydrolyzed Milk Casein.

ABSTRACT: Antimicrobial textile structures are developed based on polypropylene (PP) and a natural material, hydrolyzed casein. The casein, from bovine milk, is subjected to acid hydrolysis in aqueous media, then blended into the PP matrix in the melt phase by extrusion. The obtained blend, containing 5 wt.% of hydrolyzed casein, is then processed by a melt spinning process to get multifilaments, leading to the production knitting structures. Thanks to the addition of the hydrolyzed casein, the obtained textile showed a strong antibacterial activity towards both Gram (+) and Gram (-) bacterial strains. The addition of 5 wt.% hydrolyzed casein does not significantly impact the mechanical properties of PP in the dumbbells form, but a small decrease was observed in the tenacity of the filaments. No moisture retention was observed after the addition of hydrolyzed casein, but the rheological behavior was slightly affected. The obtained results can contribute to addressing concerns regarding nonrenewable antibacterial agents used in textile materials, particularly their effects on the environment and human health, by offering antibacterial agents from a biobased and edible substance with high efficiency. They are also promising to respond to issues of wasting dairy products and recycling them, in addition to the advantages of using melt processes.

SUBMITTER: Belkhir K

PROVIDER: S-EPMC7825562 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Antibacterial Textile Based on Hydrolyzed Milk Casein.

Belkhir Kedafi K Pillon Caroline C Cayla Aurélie A Campagne Christine C

Materials (Basel, Switzerland) 20210106 2

Antimicrobial textile structures are developed based on polypropylene (PP) and a natural material, hydrolyzed casein. The casein, from bovine milk, is subjected to acid hydrolysis in aqueous media, then blended into the PP matrix in the melt phase by extrusion. The obtained blend, containing 5 wt.% of hydrolyzed casein, is then processed by a melt spinning process to get multifilaments, leading to the production knitting structures. Thanks to the addition of the hydrolyzed casein, the obtained t ...[more]

PMID: 33419124

Similar Datasets

Project description:BackgroundIn case of cow's milk allergy (CMA), pediatric guidelines recommend for children the use of extensively hydrolyzed formulas (eHFs) as elimination diet. According to the American Academy of Pediatrics, the hypoallergenicity of each specific eHF should be tested in subjects with CMA.MethodsA prospective, multicenter trial was performed to assess the tolerance/hypoallergenicity of a thickened casein-based eHF (eHCF, Allernova AR®, United Pharmaceuticals, France) in infants aged <12 months with CMA proven by a double-blind placebo-controlled food challenge. Its efficacy, measured through allergy symptoms monitoring and Cow's Milk-related Symptom Score (CoMiSS) calculation, and safety were evaluated during a 4-month feeding period. Growth z-scores were computed based on WHO anthropometric data.ResultsThirty infants (mean age: 4.8 ± 3.0 months) with CMA proven by a DBPCFC tolerated the eHCF during the 4-month study. The CoMiSS, crying and regurgitation scores significantly decreased by 4.2 ± 4.0, 0.9 ±1.2 and 0.7 ± 1.1 respectively, after 14 days of feeding (p < 0.001). The Scoring Atopic Dermatitis index, of 33.2 ± 14.8 at inclusion in 9 patients, significantly decreased by 15.5 ± 6.7 and 21.1 ± 11.2, after 14 and 45 days of feeding, respectively (p < 0.001). The percentage of infants having normal stool consistency (soft or formed stools) significantly improved from 66.7 % (20/30) at inclusion to 90.0 % (27/30) after 14 days of feeding (p = 0.020). The growth z-scores, negative at study inclusion, significantly improved over the 4-month study. No adverse event was related to the eHCF.ConclusionThe thickened eHCF was tolerated by more than 90 % of included allergic infants with 95 % confidence interval and can therefore be considered as hypoallergenic in accordance with current guidelines. The improvement of growth indices and absence of related adverse events confirmed its safety. Results of this trial back the use of the tested thickened eHCF as an efficient and safe alternative in children with CMA.Trial registrationClinicalTrials.gov, number NCT02351531 , registered on 27 January 2015.

Dataset Information

Antibacterial Textile Based on Hydrolyzed Milk Casein.

Publications

Antibacterial Textile Based on Hydrolyzed Milk Casein.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets